ExodusPoint Capital Management »

Relmada Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $333k 69k 4.83
2024-09-30 $220k 68k 3.24
2022-09-30 $1.1M 30k 37.03
2022-06-30 $347k 18k 19.01
2020-03-31 $964k 28k 34.12
2019-12-31 $458k 12k 38.96

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Relmada Therapeutics

Marshall Wace
Ikarian Capital
Braidwell
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management
Boothbay Fund Management
Driehaus Capital Management
CI Private Wealth
Acadian Asset Management
Susquehanna International
Diadema Partners
State Street Corporation
AdvisorShares Investments

View all funds holding Relmada Therapeutics